Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1

Autor: Pery, Erez, Sheehy, Ann, Miranda Nebane, N., Misra, Vikas, Mankowski, Marie K., Rasmussen, Lynn, Lucile White, E., Ptak, Roger G., Gabuzda, Dana
Zdroj: In Virology October 2015 484:276-287
Databáze: ScienceDirect